Precision Business Insights
Portfolio

 

Latin America Over The Counter (OTC) Drugs Market

: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

Latin America Over The Counter Drugs Market by Product Type (Pain Products, Cough, Cold and Flu Products, Vitamins and Minerals, Gastrointestinal Products, Ophthalmic Products, Sleep Aid Products, Weight Loss/Diet Products, Others), by Formulation Type (Tablets, Liquids, Ointments, Sprays, Others), by Distribution Channel (Pharmacies, Supermarkets/Hypermarkets, Convenience stores, Online drugstores, Others)

 

Latin America Over the Counter Drugs Market: Over-the-counter (OTC) drugs Market, also known as the non-prescription drugs that can be bought without a prescription. Over-the-counter drugs are safe and effective when the consumer follows the directions on the label or as provided by a physician. Over-the-counter (OTC) drugs are primarily used to treat conditions that do not require direct consultation of a doctor. Over-the-counter drugs provide affordable treatment and also help to decrease the workload of physicians. Over-the-counter drugs are easily available in pharmacies. Even though these products are considered as over-the-counter because these are not directly kept on pharmacy counters and must be dispensed by a pharmacist after confirming age, identity, and patient knowledge regarding usage of the product.

 

Latin America Over The Counter Drugs Market Outlook

 

Latin America over the counter drugs market is growing at a significant CAGR due to rise in the population. Increase in the adoption of western lifestyles, promotion and marketing initiatives for over-the-counter products, the rise in the healthcare expenditure, and an increase in the geriatric population expected to fuel the Latin America Over The Counter Drugs Market over the forecast period. Furthermore, rise in demand for self-medication with non-prescription drugs, changes in cultural attitudes regarding self-medications required for minor health problems, convenience in the direct purchase, savings enabled by the use of over-the-counter drugs, and developments and innovations in drugs products expected to fuel the Latin-America over-the-counter drugs market. However, competition between the existing market players, more possibilities of substance addiction and abuse, severity and complications involved in the taking of wrong medications due to misdiagnosis and lack of awareness among the rural population in developing and underdeveloped countries might hinder the Latin America over-the-counter drugs market over the forecast period.

 

The Latin America Over The Counter Drugs Market is segmented on the basis of product type, formulation type, and distribution channel

 

Based on product type, Latin America Over The Counter (OTC) Drugs Market  has been segmented into the following:

  • Pain Products
  • Cough, Cold and Flu Products
  • Vitamins and Minerals
  • Gastrointestinal Products
  • Ophthalmic Products
  • Sleep Aid Products
  • Weight Loss/Diet Products
  • Others

 

Based on formulation type, Latin America Over The Counter (OTC) Drugs Market has been segmented into the following:

  • Tablets
  • Liquids
  • Ointments
  • Sprays
  • Others

 

Based on distribution channel, Latin America Over The Counter (OTC) Drugs Market  has been segmented into the following:

  • Pharmacies
  • Supermarkets/Hypermarkets
  • Convenience stores
  • Online drugstores
  • Others

 

The Latin America Over The Counter Drugs Market is in the flourishing stage with several local and international players actively engaged in the launch of new products to increase their market share in the Latin America over-the-counter drugs market. Some of the key strategies followed by various pharmaceutical companies include acquisitions and mergers, collaborations, and technological innovations for over-the-counter drugs. For instance, in February 2013, Reckitt Benckiser, the manufacturer of Nurofen painkillers, paid to Bristol-Myers Squibb about US$ 482 Mn to license a portfolio of Latin American over-the-counter healthcare products. Moreover, in December 2016, Perrigo Company plc received FDA approval for Nicorette over the product and the company plans to launch the product in various countries including Latin America.

 

Geographically, Latin America Over The Counter (OTC) Drugs Market segmented into the following countries such as Brazil, Mexico, Chile, Argentina, Venezuela and Rest of Latin America as these are the largest pharmaceutical markets in the region. Brazil Over The Counter Drugs Market holds the largest share, which is attributed to highest population among all Latin American countries, increase in awareness regarding the over-the-counter drugs. OTC drugs such as analgesics and contraceptives are commonly used in the Brazil. In Argentina, it is very common that a citizen can buy antibiotics without a prescription. Increase in population, advertising and marketing regarding the over-the-counter drugs, and ease of availability of over-the-counter drugs expected to fuel the Latin America over-the-counter drugs market over the forecast period.

 

Some of the players in Latin America Over The Counter (OTC) Drugs Market are Novartis AG (Switzerland), Pfizer, Inc. (U.S.), Valeant (Canada), Perrigo Company plc. (U.S.), Sanofi-Aventis (France), GlaxoSmithKline plc. (U.K.), Johnson & Johnson Services, Inc. (U.S.), Bayer AG (Germany), Takeda Pharmaceuticals company Ltd. (Japan), Teva Pharmaceutical Industries Ltd. (Israel), Bristol-Myers Squibb (U.S.), and Reckitt Benckiser Group plc (U.K.) to name a few.

 

  • In September 2017, Isodiol International Inc. planned to launch OTC products in the Latin America region

 

  • In May 2014, Bayer acquired the consumer care business of Merck & Co., Inc., in Latin America and North America regions

 

Report Outline:

 

  • The report provides granular level information about the market size, regional market share and forecast from 2017-2023
  • The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
  • The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
  • The report tracks recent innovations, key developments and startup’s details that are working in the industry
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario

1. Executive Summary
2. Latin America Over The Counter (OTC) Market Introduction
2.1. Latin America Over The Counter (OTC) Market – Taxonomy
2.2. Latin America Over The Counter (OTC) Market –Definitions
2.2.1. Product Type
2.2.2. Formulation Type
2.2.3. Distribution Channel
3. Latin America Over The Counter (OTC) Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Latin America Over The Counter (OTC) Market Dynamics – Factors Impact Analysis
3.6. Latin America Over The Counter (OTC) Market – Regulations
3.7. Latin America Over The Counter (OTC) Market – Product Innovations
4. Latin America Over The Counter (OTC) Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis
5. Latin America Over The Counter (OTC) Market, By Product, 2013 – 2017 and Forecast, 2018 – 2024
5.1. Pain Products
5.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.1.3. Market Opportunity Analysis
5.2. Cough, Cold and Flu Products
5.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.2.3. Market Opportunity Analysis
5.3. Vitamins and Minerals
5.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.3.3. Market Opportunity Analysis
5.4. Gastrointestinal Products
5.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.4.3. Market Opportunity Analysis
5.5. Ophthalmic Products
5.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.5.3. Market Opportunity Analysis
5.6. Sleep Aid Products
5.6.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.6.3. Market Opportunity Analysis
5.7. Weight Loss/Diet Products
5.7.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.7.3. Market Opportunity Analysis
5.8. Others
5.8.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.8.3. Market Opportunity Analysis
6. Latin America Over The Counter (OTC) Market Forecast, By Formulation Type, 2013 – 2017 and Forecast, 2018 – 2024
6.1. Tablets
6.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
6.1.3. Market Opportunity Analysis
6.2. Liquids
6.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
6.2.3. Market Opportunity Analysis
6.3. Ointments
6.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
6.3.3. Market Opportunity Analysis
6.4. Sprays
6.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
6.4.3. Market Opportunity Analysis
6.5. Others
6.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
6.5.3. Market Opportunity Analysis
7. Latin America Over The Counter (OTC) Market Forecast, By Distribution Channel, 2013 – 2017 and Forecast, 2018 – 2024
7.1. Pharmacies
7.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.1.3. Market Opportunity Analysis
7.2. Supermarkets/Hypermarkets
7.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.2.3. Market Opportunity Analysis
7.3. Convenience stores
7.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.3.3. Market Opportunity Analysis
7.4. Online drugstores
7.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.4.3. Market Opportunity Analysis
7.5. Others
7.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.5.3. Market Opportunity Analysis
8. Argentina Over The Counter (OTC) Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
8.1. Product Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
8.1.1. Pain Products
8.1.2. Cough, Cold and Flu Products
8.1.3. Vitamins and Minerals
8.1.4. Gastrointestinal Products
8.1.5. Ophthalmic Products
8.1.6. Sleep Aid Products
8.1.7. Weight Loss/Diet Products
8.1.8. Others
8.2. Formulation Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
8.2.1. Tablets
8.2.2. Liquids
8.2.3. Ointments
8.2.4. Sprays
8.2.5. Others
8.3. Distribution Channel Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
8.3.1. Pharmacies
8.3.2. Supermarkets/Hypermarkets
8.3.3. Convenience stores
8.3.4. Online drugstores
8.3.5. Others
8.4. Argentina Over The Counter (OTC) Market – Opportunity Analysis Index, By Product, Formulation Type, Distribution Channel and Country, 2018 – 2024
8.5. Argentina Over The Counter (OTC) Market Dynamics – Trends
9. Brazil Over The Counter (OTC) Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
9.1. Product Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Pain Products
9.1.2. Cough, Cold and Flu Products
9.1.3. Vitamins and Minerals
9.1.4. Gastrointestinal Products
9.1.5. Ophthalmic Products
9.1.6. Sleep Aid Products
9.1.7. Weight Loss/Diet Products
9.1.8. Others
9.2. Formulation Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Tablets
9.2.2. Liquids
9.2.3. Ointments
9.2.4. Sprays
9.2.5. Others
9.3. Distribution Channel Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.3.1. Pharmacies
9.3.2. Supermarkets/Hypermarkets
9.3.3. Convenience stores
9.3.4. Online drugstores
9.3.5. Others
9.4. Brazil Over The Counter (OTC) Market – Opportunity Analysis Index, By Product, Formulation Type, Distribution Channel and Country, 2018 – 2024
9.5. 9.4. Brazil Over The Counter (OTC) Market Dynamics – Trends
10. Mexico Over The Counter (OTC) Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
10.1. Product Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Pain Products
10.1.2. Cough, Cold and Flu Products
10.1.3. Vitamins and Minerals
10.1.4. Gastrointestinal Products
10.1.5. Ophthalmic Products
10.1.6. Sleep Aid Products
10.1.7. Weight Loss/Diet Products
10.1.8. Others
10.2. Formulation Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Tablets
10.2.2. Liquids
10.2.3. Ointments
10.2.4. Sprays
10.2.5. Others
10.3. Distribution Channel Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Pharmacies
10.3.2. Supermarkets/Hypermarkets
10.3.3. Convenience stores
10.3.4. Online drugstores
10.3.5. Others
10.4. Mexico Over The Counter (OTC) Market – Opportunity Analysis Index, By Product, Formulation Type, Distribution Channel and Country, 2018 – 2024
10.5. 9.4. Mexico Over The Counter (OTC) Market Dynamics – Trends
11. Rest of Latin America Over The Counter (OTC) Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
11.1. Product Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Pain Products
11.1.2. Cough, Cold and Flu Products
11.1.3. Vitamins and Minerals
11.1.4. Gastrointestinal Products
11.1.5. Ophthalmic Products
11.1.6. Sleep Aid Products
11.1.7. Weight Loss/Diet Products
11.1.8. Others
11.2. Formulation Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Tablets
11.2.2. Liquids
11.2.3. Ointments
11.2.4. Sprays
11.2.5. Others
11.3. Distribution Channel Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Pharmacies
11.3.2. Supermarkets/Hypermarkets
11.3.3. Convenience stores
11.3.4. Online drugstores
11.3.5. Others
11.4. Rest of Latin America Over The Counter (OTC) Market – Opportunity Analysis Index, By Product, Formulation Type, Distribution Channel and Country, 2018 – 2024
11.5. 9.4. Rest of Latin America Over The Counter (OTC) Market Dynamics – Trends
12. Competition Landscape
12.1. Strategic Dashboard of Top Market Players
12.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
12.2.1. Novartis AG (Switzerland)
12.2.2. Pfizer, Inc. (U.S.)
12.2.3. Valeant (Canada)
12.2.4. Perrigo Company plc. (U.S.)
12.2.5. Sanofi (France)
12.2.6. GlaxoSmithKline plc. (U.K.)
12.2.7. Johnson & Johnson Services, Inc. (U.S.)
12.2.8. Bayer AG (Germany)
12.2.9. Takeda Pharmaceuticals company Ltd. (Japan)
12.2.10. Teva Pharmaceutical Industries Ltd. (Israel)
12.2.11. Bristol-Myers Squibb (U.S.)
12.2.12. Reckitt Benckiser Group plc (U.K.)
13. Research Methodology
14. Key Assumptions and Acronyms

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

 

$ 3,000.00$ 8,900.00
Clear selection

Select License Type

Databank $ 3,000.00
spinner
Single User $ 4,400.00
spinner
Multiple User $ 6,600.00
spinner
Corporate User $ 8,900.00
spinner
buy now spinner
FacebookTwitterLinkedinEmail

Our Clients

Testimonials